BioSig Announces Closing of Public Offering of Common Stock

February 25, 2020

BioSig Announces $10 Million Public Offering of Common Stock

February 21, 2020

BioSig Announces Proposed Public Offering of Common Stock

February 20, 2020

BioSig Completes 100th Patient Case with PURE EP(TM) System

February 19, 2020

BioSig to Present at the 25th Annual International AF Symposium

January 21, 2020

BioSig to Commence Patient Cases at Mayo Clinic

January 16, 2020

BioSig Awarded Additional US Patent Claims for its PURE EP(TM) System

January 14, 2020

BioSig Technologies Announces New Collaboration on Development of Artificial Intelligence Solutions in Healthcare

December 3, 2019

BioSig Technologies Signs Three New Licensing Agreements with Mayo Clinic

November 26, 2019

BioSig Commences Clinical Trial Enrollment for PURE EP System

November 21, 2019